Cited by 51Mycobacterium research and diagnosisActinomycetales infections and treatmentTuberculosis Research and Epidemiology

Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients

Open access
Asakura, Takanori, Funatsu, Yohei, Ishii, Makoto, Namkoong, Ho, Yagi, Kazuma, Suzuki, Shoji, Asami, Takahiro, Kamo, Tetsuro +6 more·2015·Respiratory Research

Abstract

BACKGROUND: Mycobacterium avium complex (MAC) lung diseases generally cause chronic disease in immunocompetent hosts. Although a few studies have examined health-related quality of life (HRQL) in patients with MAC lung disease, there have been no large studies. This study aimed to evaluate HRQL and its correlation with clinical outcomes in MAC lung disease. METHODS: A cross-sectional study was conducted at Keio University Hospital to investigate the factors associated with HRQL in pulmonary nontuberculous mycobacterial diseases. MAC lung diseases were diagnosed according to the 2007 ATS/IDSA guidelines for nontuberculous mycobacterial diseases. The 36-item short form health survey (SF-36) was administered to assess clinical outcomes. Clinical variables included treatment status, latest haematological data, and bacterial smear and culture results. RESULTS: The SF-36 scores for the 235 patients (median age, 69 years; 45 men and 190 women) with MAC lung disease, except for the bodily pain and mental health subscale scores, were significantly lower than the Japanese population norms. In the multivariable analyses, current treatment for MAC and a positive sputum smear or culture within the past year were significantly associated with lower SF-36 scores. C-reactive protein (CRP) and age showed stronger inverse correlations with SF-36 scores. CONCLUSIONS: HRQL, especially the physical component, was impaired in patients with MAC lung diseases; this appears to be related with current treatment status, positive sputum smear or culture within the previous year, and particularly CRP and age. Further studies including qualitative assessments are needed to investigate the efficacy of CRP as a marker for progression or treatment response in MAC lung disease. TRIAL REGISTRATION: Clinical trial registered with UMIN ( UMIN000007964 ).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12931-015-0304-5

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Asakura, T., Funatsu, Y., Ishii, M., Namkoong, H., Yagi, K., Suzuki, S., Asami, T., Kamo, T., Fujiwara, H., Uwamino, Y., Nishimura, T., Tasaka, S., Betsuyaku, T., & Hasegawa, N.
Affiliations
Keio University (JP)
Corresponding author
Ishii, Makoto
Venue
Respiratory Research
Published
2015-12
Volume
16
Issue
1
Pages
145-145
ISSN
  • 1465-9921 (ISSN-L)
  • 1465-993X
OpenAlex
W2183042421
Cited by
51
References
38
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 6 · 2019: 2 · 2018: 10 · 2017: 4 · 2016: 1
FWCI
3.92
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Respiratory Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (26860772)
Topics
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
  • Health Sciences › Medicine › Microbiology › Actinomycetales infections and treatment
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
Mycobacterium avium complex, nontuberculous mycobacterial lung disease, health-related quality of life, C-reactive protein, age, SF-36, physical component, sputum smear and culture, tuberculosis treatment, chronic lung disease
MeSH terms
Aged, Aging, C-Reactive Protein, Cross-Sectional Studies, Female, Health Surveys, Humans, Lung Diseases, Male, Middle Aged, Quality of Life, Risk Factors, Sputum, Mycobacterium avium-intracellulare Infection, Biomarkers, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review